NEWS UPDATE –1 – 8 March 2013

NEWS UPDATE –1 – 8 March 2013
Research and Markets: PharmaPoint: Seasonal Influenza Vaccines - Current and
Future Players
Fri, 08 Mar 2013 07:54:50 GMT|Business Wire (press release)|
The report provides an up-to-date information and analysis of the key companies shaping and
driving the global Seasonal Influenza market. It is built on data and information sourced from
proprietary databases, primary and secondary and in-house analysis by the team of industry
experts.
Is the flu vaccine worth the effort?
Sun, 03 Mar 2013 23:51:41 GMT| National NZ Herald News
Health authorities are looking to extend free flu vaccinations to all preschoolers. We investigate
whether the flu jab works - and whether it is worth the millions of dollars the taxpayer spends
subsidising it. For some government economists, investment in free flu jabs for retirees and preschoolers may seem hard to justify. Preliminary findings from the five-year Shivers (Southern
Hemisphere Influenza Vaccine Effectiveness Research and Surveillance) study reveal the impact
on those aged over 65, or under 4 years.
Study: Getting flu shot 2 years in a row may lower protection - Cidrap ...
Sat, 02 Mar 2013 17:38:32 GMT| CIDRAP
Experts are puzzled by a new study in which influenza vaccination seemed to provide little or no
protection against flu in the 2010-11 season—and in which the only participants who seemed to
benefit from the vaccine were those who hadn't been vaccinated the season before.
The investigators recruited 328 households in Michigan before the flu season started and
followed them through the season. Overall, they found that the infection risk was nearly the same
in vaccinated and unvaccinated participants, indicating no significant vaccine-induced protection,
according to their report in Clinical Infectious Diseases. That contrasted sharply with several
other observational studies that found the vaccine to yield about 60% protection during the same
season.
Swine Flu Vaccine Causes Narcolepsy In Children? Research Finds
Strange Association
Thu, 28 Feb 2013 04:58:03 GMT|PlanetSave.com|
New research published in the British Medical Journal has found a greatly increased risk of
narcolepsy in the children and teenagers who were vaccinated against the A/H1N1 2009 influenza
in England. This research reinforces the findings of previous studies done in Sweden and Finland,
which found that the vaccine Pandremix increased the risk of narcolepsy.
Grippe: le bénéfice de la vaccination
Thu, 28 Feb 2013 00:00:00 GMT
La grippe de cette année affecte particulièrement la tranche d’âge 15-65 ans alors que les
précédentes s’attaquaient plutôt aux enfants et aux plus de 65 ans. Dans les formes sévères, c’està-dire qui nécessitent une hospitalisation, on dénombre essentiellement des personnes atteintes
de maladies chroniques (respiratoires, cardiaques, diabétiques). Les experts notent des argument
en faveur de la vaccination contre la grippe ».
L’épidémie de grippe, en forte baisse, va durer encore un mois
Thu, 28 Feb 2013 00:00:00 GMT
« Il est un peu tard pour se vacciner contre la grippe cette année. Mais il faut évidemment voir
avec son propre médecin» dit le Dr Yves Thomas responsable du Centre national de référence de
l’influenza (CNRI) basé aux hôpitaux universitaires de Genève.
Newcastle search for bird flu vaccine
ABC (Australia), 26 February 2013
Newcastle is part of a global vaccine project being funded by the US Government to combat the
danger of avian influenza, or bird flu. Aaron Kearney from 1233 ABC Newcastle found out about
local research that's being done to try to make sure an effective vaccine is available. He spoke to
Dr Marc Russo, director of Hunter Clinical Research.
Global Immunization News February 2013 Issue
Inside this issue:
- PAHO Revolving Fund Makes Influenza Vaccines More Available to Countries
- Guidance on development and implementation of a national deployment and vaccination plan
for pandemic influenza vaccines
Economic benefits of inactivated influenza vaccines in the prevention of seasonal
influenza in children
Luis Salleras, Encarna Navas, Nuria Torner, Andreu A. Prat, Patricio Garrido, Núria Soldevila and
Angela Domínguez